| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | 17-AAG | CCLE | pan-cancer | AAC | 0.13 | 0.01 |
| mRNA | WH-4-023 | GDSC1000 | pan-cancer | AAC | -0.12 | 0.01 |
| mRNA | Vinblastine | GDSC1000 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Bosutinib | GDSC1000 | pan-cancer | AAC | -0.085 | 0.01 |
| mRNA | MK-2206 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.01 |
| mRNA | Cytarabine | GDSC1000 | pan-cancer | AAC | -0.089 | 0.01 |
| mRNA | NVP-BEZ235 | GDSC1000 | pan-cancer | AAC | -0.086 | 0.01 |
| mRNA | BRD-K55116708 | CTRPv2 | pan-cancer | AAC | 0.097 | 0.02 |
| mRNA | tipifarnib | CTRPv2 | pan-cancer | AAC | 0.08 | 0.02 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | 0.092 | 0.02 |